mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.05 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.05 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.05 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.05 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.05 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |